SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,235 | +79.2% | 43,182 | +69.3% | 0.25% | +93.7% |
| Q2 2023 | $2,922 | +0.8% | 25,512 | +21.3% | 0.13% | -7.3% |
| Q1 2023 | $2,899 | -57.2% | 21,032 | -59.7% | 0.14% | -63.5% |
| Q4 2022 | $6,770 | -99.9% | 52,244 | -13.9% | 0.38% | -7.4% |
| Q3 2022 | $6,706,000 | +107.1% | 60,670 | +40.5% | 0.40% | +66.7% |
| Q2 2022 | $3,238,000 | -11.8% | 43,191 | -8.1% | 0.24% | +1.2% |
| Q1 2022 | $3,672,000 | +192.6% | 47,003 | +237.3% | 0.24% | +52.9% |
| Q4 2021 | $1,255,000 | -2.6% | 13,937 | 0.0% | 0.16% | -8.7% |
| Q3 2021 | $1,289,000 | +31.0% | 13,937 | +127.1% | 0.17% | -48.5% |
| Q2 2020 | $984,000 | – | 6,138 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |